---
title: "Translation on Demand as a post-transcriptional regulation mechanism of embryonic stem cell differentiation"
subtitle: "Master Thesis Defense"
author: "Elias Schwall"
loop: true
date: today
logo: CECAD_logo.jpg
css: style.css
format: 
  revealjs:
    slide-number: true
include-in-header:
  - text: |
      <style>
      #title-slide .title {
        font-size: 1.5em;
      }
      </style>
include-after: |
  <script type="text/javascript">
    Reveal.on('ready', event => {
      if (event.indexh === 0) {
        document.querySelector("div.has-logo > img.slide-logo").style.display = "none";
      }
    });
    Reveal.addEventListener('slidechanged', (event) => {
      if (event.indexh === 0) {
        Reveal.configure({ slideNumber: null });
        document.querySelector("div.has-logo > img.slide-logo").style.display = "none";
      }
      if (event.indexh === 1) { 
        Reveal.configure({ slideNumber: 'c/t' });
        document.querySelector("div.has-logo > img.slide-logo").style.display = null;
      }
    });
  </script>
---



## What is Translation on Demand (ToD)? {.smaller}

:::::: columns
:::: {.column width="60%" .incremental}
::: callout-note
# ToD

is described as a **selective** and **rapid** protein synthesis for specific mRNAs **without increased mRNA levels**
:::

-   quick cellular responses during transitions, stresses and signaling stumuli
-   **Neurons:** Local translation at active synapses
-   **Early Embryos:** Stored maternal mRNAs are activated after fertilization
-   **Stress Response:** Rapid synthesis of stress proteins (e.g. heat shock proteins) when needed
::::

::: {.column width="40%"}
![](figures/defense_specific/Translation_on_Demand_Info_graphic.png){height="600"}
:::
::::::

## Why should we care?

:::{.r-stack}

:::{.fragment .fade-in}
:::{.fragment .fade-out}
::: callout-tip
## Transcript-Protein Relationship
RNA levels can not fully explain protein abundance for many genes
:::

![](figures/defense_specific/Transcript_RNA_relation.png)
:::
:::

:::{.fragment .fade-in .incremental}
::: callout-tip
## Mouse vs Human Development
- mESCs differentiate/develop much faster than hESCs 
- maybe ToD is a key mechanism that allows this speed 
- e.g. enabling the upregulation of key genes to switch gene regulatory networks quickly
:::

:::
:::


## [ToD may be a key regularoty machanism during development]{.r-fit-text}

:::{.r-stack}
![edited from Strell et al. 2022](figures/defense_specific/ESCs_1.png){width=90%}

![edited from Strell et al. 2022](figures/defense_specific/ESCs.png){.fragment width=90%}
:::


## How are we studying ToD? - 2i Media {.smaller}

::::: columns
:::: {.column width="60%"}

::: {.fragment}
::: callout-caution
## <span style="color: green">GSK3 Inhibitor (CHIR99021)</span>
- Inhibits GSK3 to stabilize β-catenin, promoting Wnt signaling
- Supports pluripotency and helps prevent differentiation
:::
:::

![Fabian Titz-Teixeira PhD Thesis](figures/defense_specific/2i_media.png)
::::
 
:::: {.column width="40%"}

::: {.fragment}
::: callout-caution
## <span style="color: orange">MEK Inhibitor (PD0325901)</span>

- Blocks the ERK pathway to decrease differentiation signalling
:::
:::

::: {.fragment}
::: callout-tip
## The basic idea
Remove 2i → Perform –omics over a timecourse → Analyze changes in genes and their products
:::
:::

::::

:::::

## Project Goals

::: {layout-nrow=2}
::: callout-tip
# [1] Identifying ToD regulated genes
Framework for filtering ToD candidates by comparing transcriptome and proteome layers
:::

::: {.fragment}
::: callout-caution
# [2] What processes are subject to ToD?
Define gene sets / Functional enrichment and annotation 
:::
:::

::: {.fragment}
::: callout-caution
# [3] Why are these processes ToD-regulated?
Are those processes critical for transitioning out of the naive state?
:::
:::

::: {.fragment}
::: callout-caution
# [4] How is ToD facilitated by cells?
What are the mechanisms enabling ToD? E.g. regulatory elements in 5' UTRs, 3' UTRs, RNA binding proteins, etc.
:::
:::
::: 

## [Experimental Approach, Datasets and Workflow]{.r-fit-text}

::::: columns
:::: {.column width="80%"}
![](figures/defense_specific/Master_Thesis_Project_Overview.png)
:::: 
:::: {.column width="20%"}

:::: 
:::::

:::{.fragment}
![](figures/defense_specific/ToDcallR_hex.png){.absolute bottom=150 right=-70 width="380" height="300"}
:::

## [How can we detect ToD candidates?]{.r-fit-text}{.smaller}

::: callout-note
## Filter for stable transcripts
$$ -R_s \leq \text{LFC}_{\text{between time points}} \leq R_s$$
:::

::::: columns
:::: {.column width="50%"}

::: {.fragment fragment-index=1}
![](figures/defense_specific/stable_range.png){width=70%}
:::

::::
:::: {.column width="50%"}

::: {.fragment fragment-index=2}
```{r}
#| eval: false
#| echo: true
#| code-line-numbers: "|5"
DESeq2::results(
      ToDcall@dds,
      contrast = contrasts[[comparison]],
      lfcThreshold = stable_transcript_range,
      altHypothesis = "lessAbs"
)
```
:::
::::
::::: 




## [How can we detect ToD candidates?]{.r-fit-text}{.smaller}


::: callout-note
## Calculate the LFC ratio
$$\text{(1) LFC-Ratio} = \text{logFC}_{\text{between time points protein}} - \text{logFC}_{\text{between time points RNA}}$$
$$\text{(2) LFC-Ratio}\geq \text{ToD-threshold}$$
:::


:::{.fragment}
![](figures/defense_specific/yang_ratio_plot.svg)
:::

## [How can we detect ToD candidates?]{.r-fit-text}{.smaller}

::: callout-note
## Look at protein trajectory
$$\text{logFC}_{\text{protein against 0h after ToD call}}\geq \text{logFC}_{\text{protein against 0h during ToD call}} \times (1-R_d)$$
:::

:::{.fragment}
![](figures/defense_specific/LFC_good_bad.png)
:::

## [Early time intervals experience more ToD]{.r-fit-text}

![](figures/defense_specific/tod_numbers.svg)

## What processes are being prioritized?
![](figures/ORA_plot.svg)

## [ToD candidates as Transcription factors]{.r-fit-text}

```{mermaid}
flowchart LR

%% Classes
classDef box fill:#eef4ff,stroke:#7aa0ff,stroke-width:2px,color:#1a1f36
classDef box2 fill:#f1e8ff,stroke:#9b59b6,stroke-width:2px,color:#1a1f36
classDef box3 fill:#fff1e6,stroke:#e67e22,stroke-width:2px,color:#1a1f36
classDef box4 fill:#e9fbf0,stroke:#27ae60,stroke-width:2px,color:#1a1f36
classDef pill fill:#cfdcff,stroke:#7aa0ff,color:#1a1f36
classDef pill2 fill:#d8c6ff,stroke:#9b59b6,color:#1a1f36
classDef pill3 fill:#ffd9bf,stroke:#e67e22,color:#1a1f36
classDef pill4 fill:#c7f5db,stroke:#27ae60,color:#1a1f36

subgraph A [Identify Translation-on-Demand - ToD Genes]
  direction TB
  A1("Yang time-course: keep genes where Protein LFC >> RNA LFC\nRNA in stable window\n-2 <= RNA LFC <= +2")
  A2("438 ToD genes")
end

subgraph B [Isolate Transcription Factors]
  direction TB
  B1("Cross-check ToD list with AnimalTFDB v4\nTFs over-represented")
  B2("46 TFs (10.5% of 438 ToD genes)\nFisher exact p = 0.021")
end

subgraph C [Infer TF Activity]
  direction TB
  C1("decoupleR (ULM)\nEvery TF-target link has sign\n+1 activator (targets up when TF active)\n-1 repressor (targets down when TF active)\nULM regresses target expression on signed weights\nActivator up OR repressor down => positive t-value\nOpposite => negative t-value")
  C2("t-value = TF activity score -> heatmap")
end

subgraph D [Retain TFs with Mapped Targets]
  direction TB
  D1("TFs have curated regulatory networks in CollecTRI")
  D2("22 TFs -> taken forward")
end

A -->|Filter for TFs| B
B -->|Estimate activity| C
C -->|Keep TFs with mapped targets| D

class A1 box
class A2 pill
class B1 box2
class B2 pill2
class C1 box3
class C2 pill3
class D1 box4
class D2 pill4

```


## [ToD candidates as Transcription factors]{.r-fit-text}
::::: columns
::::{.column width="60%"}
![](figures/defense_specific/TF_heatmap.svg)
::::
::::{.column width="40%"}
::::
:::::


## [How are these genes selectively post-transcriptionally upregulated?]{.r-fit-text}
![](figures/motif_plot.svg)


## The picture so far...

::: callout-tip
## Insights
 - ToD is a detectable post-trascriptional regulatory mechanism during early develompent
 - ToD aids correct transition from the naive to the formative state
 - The biological implications from the data agrees with the proposed purpose of ToD
:::

::: {.fragment}
::: callout-important
## Signal strenght
We do not have strong biological signals… e.g. in the enrichments, motif enrichmets etc.
:::
:::

## Other potential problems
::: {.fragment}
::: callout-caution
## Noise in ToD calling
We should test out other ToD calling methods.
:::
:::

::: {.fragment}
::: callout-caution
## Medium Change Stress confounding
Some LFC-ratios might be confounded by cellular stress during the medium change. Rapid development and stress are sometimes hard to differentiate.
:::
:::

::: {.fragment}
::: callout-caution
## Reproducability
ToD candidates in other datasets are hard to replicate.
:::
:::

## Whats up next?
- Polysome profiling
- Human dataset ToD calling 
- Other data normalization methods (GPR, LOESS) → better suitable for temporal data with small replicate number 


## Thank you so much, Beyer Crew! {.smaller background-color="white"}

::::: columns

::::{.column width="50%" .smaller}

Supervisor: 

special thanks to **Luke Brandwood**

![](figures/defense_specific/luke_backpack.png){width=60%}

Reviewers: 

a huge thanks goes to...

- **Prof. Dr. Andreas Beyer** 
- **Prof. Dr. Achim Tresch**

::::

::::{.column width="50%"}

::: {layout="[[1],[1,1]]"}
![](figures/defense_specific/Beyer_lab.jpg){width=90%} 

![](Uni_Köln_Logo.png){width=50%} 

![](CECAD_logo.jpg){width=50%}
:::

::::

:::::

## Datasets for Translation on Demand {.smaller}

| Dataset                          | Temporal resolution       | Replicates Transcriptomics | Replicates Proteomics | Organism |
|:---------------------------------|:--------------------------|:--------------------------|:----------------------|:---------|
| <span style="color: red;">Yang Data</span> | 0, 1, 6, 12, 24, 48, 72   | 2                          | 4                     | Mice     |
| Leeb TC Data (Time Course)       | 0, 4, 8, 12, 24, 32       | 1                          | 4                     | Mice     |
| Leeb (MC) Data Medium Change     | 0, 4, 8                   | 3                          | 4                     | Mice     |
| Leeb Human TC                    | 0, 1, 12, 48, 72, 96      | 2                          | 4                     | Human    |

- In the making: Polysome Profiling

## Testing out data smoothing methods

![](figures/defense_specific/comparison_of_smoothers.png)

## ToD candidates in other datasets
![](figures/early_tods_venn_diagram.svg)
